CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH‐NF‐κB signalling pathway. Issue 4 (15th February 2019)

• Record Type: Journal Article
• Authors: Qin, Yuexiang; Wang, Juncheng; Zhu, Gangcai; Li, Guo; Tan, Haolei; Chen, Changhan; Pi, Leiming; She, Li; Chen, Xiyu; Wei, Ming; Li, Zhexuan; Liu, Zhifeng; Huang, Donghai; Liu, Yong; Zhang, Xin
• Is Part Of: Journal of cellular and molecular medicine. Volume 23:Issue 4(2019)
• Page Start: 2689
• Page End: 2701
• Publication Date: 2019-02-15
• Subjects: CCL18 -- EMT -- metastasis -- MTDH -- SCCHN; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.14168
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: Metastasis is one of the primary causes for high mortality in patients with squamous cell carcinoma of the head and neck (SCCHN). Our previous study showed that chemokine (C‐C motif) ligand 18 (CCL18), derived from tumour‐associated macrophages (TAMs), regulates SCCHN metastasis by promoting epithelial‐mesenchymal transition (EMT) and preserving stemness. However, the underlying mechanism needs to be further investigation. Interestingly, metadherin (MTDH) expression was induced when SCCHN cells were stimulated with recombinant CCL18 protein in this study. Suppressing MTDH expression reversed CCL18‐induced migration, invasion and EMT in SCCHN cells. Furthermore, the NF‐κB signalling pathway was involved in the MTDH knock‐down cells with CCL18 stimulation. We performed ELISA to evaluate the CCL18 levels in the serums of 132 treatment‐naive SCCHN patients, 25 patients with precancerous lesion and 32 healthy donors. Our results demonstrated that serum CCL18 levels were significantly higher in SCCHN patients than patients with precancerous lesion and healthy individuals. CCL18 levels were found to be significantly correlated with tumour classification, clinical stage, lymph node metastasis and histological grade in SCCHN patients. Thus, our findings suggest that CCL18 may serve as a potential biomarker for diagnosis of SCCHN and promote SCCHN invasion, migration and EMT by MTDH‐NF‐κB signalling pathway.